Live Breaking News & Updates on Paratek Pharmaceutical

Stay updated with breaking news from Paratek pharmaceutical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Paratek Pharmaceuticals, Inc. Forecasted to Earn Q1 2023 Earnings of ($0.27) Per Share (NASDAQ:PRTK)

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) – Equities researchers at HC Wainwright lowered their Q1 2023 earnings estimates for Paratek Pharmaceuticals in a report issued on Monday, March 20th. HC Wainwright analyst E. Arce now forecasts that the specialty pharmaceutical company will post earnings per share of ($0.27) for the quarter, down from their […] ....

Prospera Financial Services Inc , Ci Private Wealth , Arete Wealth Advisors , Paratek Pharmaceuticals Company Profile , Hedge Funds Weigh In On Paratek Pharmaceuticals , Paratek Pharmaceuticals , Paratek Pharmaceuticals Inc , News Ratings For Paratek Pharmaceuticals Daily , Paratek Pharmaceuticals Stock Performance , Get Rating , Paratek Pharmaceutical , Financial Services Inc , Street Group , Wealth Advisors , Exoduspoint Capital Management , Paratek Pharmaceuticals Daily , Nasdaq Prtk , Earnings Estimates , Hc Wainwright ,

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) Expected to Announce Earnings of -$0.35 Per Share

Analysts expect that Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Get Rating) will announce ($0.35) earnings per share (EPS) for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Paratek Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.35) and the highest estimate coming in at ($0.34). Paratek Pharmaceuticals reported earnings […] ....

Goldman Sachs Group Inc , Paratek Pharmaceuticals , Zacks Investment Research , Paratek Pharmaceuticals Inc , Worth Venture Partners , J Goldman Co , Paratek Pharmaceuticals Company Profile Get Rating , Get Rating , Paratek Pharmaceutical , Investment Research , Venture Partners , Springs Capital Management , Sachs Group , Street Corp , Pharmaceuticals Company Profile , Nasdaq Prtk ,